Skip to main content

Table 3 Descriptive statistics of NA distribution in AZ inhouse and ChEMBL data sets

From: Nonadditivity in public and inhouse data: implications for drug design

  Observations Mean Variance Std Skewness Kurtosis
AstraZeneca 3,053,055 0 0.42 0.65 0 3.13
ChEMBL 1,246,975 0 0.46 0.68 0.01 4.52
  1. Note that all NA values have not been converted to absolute values prior to these calculations